207 related articles for article (PubMed ID: 25544759)
21. [Effects of FBI-1 silencing on proliferation and apoptosis of triple-negative breast cancer cell line MDA-MB-231].
Chen MJ; Wang L; Yang WP; Qin QH; Tan QX; Lian B; Wei CY
Sheng Li Xue Bao; 2018 Oct; 70(5):497-503. PubMed ID: 30377688
[TBL] [Abstract][Full Text] [Related]
22. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest.
Guan X; Guan Y
J BUON; 2020; 25(3):1330-1336. PubMed ID: 32862573
[TBL] [Abstract][Full Text] [Related]
23. Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development.
Pattarawat P; Wallace S; Pfisterer B; Odoi A; Wang HR
Cancer Chemother Pharmacol; 2020 Jan; 85(1):141-152. PubMed ID: 31865420
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
Wang M; Ma X; Wang J; Wang L; Wang Y
Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
[TBL] [Abstract][Full Text] [Related]
25. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
27. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
28. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
29. Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.
Li J; Jiang K; Qiu X; Li M; Hao Q; Wei L; Zhang W; Chen B; Xin X
BMB Rep; 2014 Jan; 47(1):33-8. PubMed ID: 24209634
[TBL] [Abstract][Full Text] [Related]
30. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
31. Peptide density targets and impedes triple negative breast cancer metastasis.
Liu D; Guo P; McCarthy C; Wang B; Tao Y; Auguste D
Nat Commun; 2018 Jul; 9(1):2612. PubMed ID: 29973594
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer.
Yan H; Luo B; Wu X; Guan F; Yu X; Zhao L; Ke X; Wu J; Yuan J
Int J Biol Sci; 2021; 17(10):2606-2621. PubMed ID: 34326697
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
[TBL] [Abstract][Full Text] [Related]
34. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis.
Feng Z; Xia Y; Gao T; Xu F; Lei Q; Peng C; Yang Y; Xue Q; Hu X; Wang Q; Wang R; Ran Z; Zeng Z; Yang N; Xie Z; Yu L
Cell Death Dis; 2018 Sep; 9(10):1006. PubMed ID: 30258182
[TBL] [Abstract][Full Text] [Related]
35. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
Al-Bahlani SM; Al-Bulushi KH; Al-Alawi ZM; Al-Abri NY; Al-Hadidi ZR; Al-Rawahi SS
Clin Breast Cancer; 2017 Jun; 17(3):e103-e112. PubMed ID: 28089626
[TBL] [Abstract][Full Text] [Related]
37. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer.
Hou Q; Lin X; Lu X; Bai C; Wei H; Luo G; Xiang H
Bioorg Med Chem; 2020 Dec; 28(23):115763. PubMed ID: 32992255
[TBL] [Abstract][Full Text] [Related]
39. WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance.
Zheng H; Shao F; Martin S; Xu X; Deng CX
Sci Rep; 2017 Mar; 7():43517. PubMed ID: 28262781
[TBL] [Abstract][Full Text] [Related]
40. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
